Evidence map›Paper›PMID 35122045›Full record

ArticleNature cancer2020

Publisher Correction: Zeb2 drives invasive and microbiota-dependent colon carcinoma.

Karolina Slowicka, Ioanna Petta, Gillian Blancke, Esther Hoste, Emilie Dumas, Mozes Sze, Hanna Vikkula, Enrico Radaelli, Jody J Haigh, Sven Jonckheere and 18 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Karolina Slowicka *VIB Center for Inflammation Research, Ghent, Belgium.
Ioanna Petta *VIB Center for Inflammation Research, Ghent, Belgium.
Gillian BlanckeVIB Center for Inflammation Research, Ghent, Belgium.
Esther HosteVIB Center for Inflammation Research, Ghent, Belgium.ORCID http://orcid.org/0000-0002-3181-431X
Emilie DumasVIB Center for Inflammation Research, Ghent, Belgium.
Mozes SzeVIB Center for Inflammation Research, Ghent, Belgium.
Hanna VikkulaVIB Center for Inflammation Research, Ghent, Belgium.
Enrico RadaelliKU Leuven Center for Human Genetics, Leuven, Belgium.ORCID http://orcid.org/0000-0002-2885-0221
Jody J HaighResearch Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
Sven JonckheereDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Joachim TaminauDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Niels VandammeVIB Center for Inflammation Research, Ghent, Belgium.
Andy WullaertVIB Center for Inflammation Research, Ghent, Belgium.
Eugene TulchinskyUniversity of Leicester, Leicester, UK.
David NittnerHistopathology Expertise Center, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Pieter Van VlierbergheCancer Research Institute Ghent, Ghent, Belgium.ORCID http://orcid.org/0000-0001-9063-7205
Gert De HertoghDepartment of Pathology, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Pamela BaldinDepartment of Pathology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.
Emre EtliogluDepartment of Oncology, University Hospital Leuven, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-4267-1307
Pratyaksha WirapatiSwiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-0327-4686
Louis BoonBioceros, Utrecht, the Netherlands.
Bart N LambrechtVIB Center for Inflammation Research, Ghent, Belgium.
Chris CallewaertCenter for Microbial Ecology and Technology, Ghent University, Ghent, Belgium.
Sabine TejparDepartment of Oncology, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Steven GoossensDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Geert BerxDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. geert.berx@ugent.be.ORCID http://orcid.org/0000-0001-5770-2458
Lars VereeckeVIB Center for Inflammation Research, Ghent, Belgium. lars.vereecke@irc.vib-ugent.be.
Geert van LooVIB Center for Inflammation Research, Ghent, Belgium. geert.vanloo@irc.vib-ugent.be.ORCID http://orcid.org/0000-0002-8427-4775

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35122045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.